Soricimed Biopharma inc. débute la conception et le développement d'un conjugué biologique de médicament
18 juil. 2012 07h30 HE
|
Soricimed Biopharma inc.
TORONTO, ONTARIO--(Marketwire - 18 juillet 2012) - Soricimed Biopharma Inc, société privée spécialisée dans le développement de thérapies et d'outils de...
Soricimed Biopharma Inc. Commences the Design and Development of Biologic Drug Conjugates
18 juil. 2012 07h30 HE
|
Soricimed Biopharma Inc.
TORONTO, ONTARIO--(Marketwire - July 18, 2012) - Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, is collaborating with Mount Allison...
Soricimed Biopharma Inc. Attending 2012 BIO International
14 juin 2012 07h30 HE
|
Soricimed Biopharma Inc.
TORONTO, CANADA--(Marketwire - June 14, 2012) - Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, will be exhibiting with the Atlantic...
Soricimed Biopharma Inc. Receives IND Clearance to Commence Phase I Trial of New Cancer Drug
29 mai 2012 07h30 HE
|
Soricimed Biopharma Inc.
TORONTO, CANADA--(Marketwire - May 29, 2012) - Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, is pleased to announce that the...